QUETIAPINE IMPROVES VISUAL HALLUCINATIONS IN PARKINSON DISEASE BUT NOT THROUGH NORMALIZATION OF SLEEP ARCHITECTURE: RESULTS FROM A DOUBLE-BLIND CLINICAL-POLYSOMNOGRAPHY STUDY-Reference-Cited by-同舟云学术

QUETIAPINE IMPROVES VISUAL HALLUCINATIONS IN PARKINSON DISEASE BUT NOT THROUGH NORMALIZATION OF SLEEP ARCHITECTURE: RESULTS FROM A DOUBLE-BLIND CLINICAL-POLYSOMNOGRAPHY STUDY

Published:2009-10-19 Issue:12 Volume:119 Page:2196-2205
ISSN:0020-7454
Container-title:International Journal of Neuroscience
language:en
Short-container-title:International Journal of Neuroscience

Author:

FERNANDEZ HUBERT H.,OKUN MICHAEL S.,RODRIGUEZ RAMON L.,MALATY IRENE A.,ROMRELL JANET,SUN ANQI,WU SAMUEL S.,PILLARISETTY SANDEEP,NYATHAPPA ANAND,EISENSCHENK STEPHAN

Publisher

Informa UK Limited

Subject

General Medicine,General Neuroscience

Link

http://www.tandfonline.com/doi/pdf/10.3109/00207450903222758

Reference14 articles.

1. Parkinson's disease and sleepiness: An integral part of PD

2. Polysomnographic sleep measures in Parkinson's disease patients with treatment-induced hallucinations

3. Scales to assess psychosis in Parkinson's disease: Critique and recommendations

4. Long-term outcome of quetiapine use for psychosis among parkinsonian patients

5. Atypical Antipsychotics in Parkinson-Sensitive Populations

Cited by 93 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clearing the Fog: A Review of Antipsychotics for Parkinson's-Related Hallucinations: A Focus on Pimavanserin, Quetiapine and Clozapine;Journal of Integrative Neuroscience;2024-04-12

2. Second-generation antipsychotics for Parkinson's disease psychosis: A systematic review and network meta-analysis;General Hospital Psychiatry;2024-03

3. Parkinson’s disease psychosis management: an evidence based, experience informed, pragmatic approach;Expert Opinion on Pharmacotherapy;2024-01-22

4. Unilateral anterior capsulotomy combined with deep brain stimulation for Parkinson's disease psychosis and motor dysfunctions;Progress in Neuro-Psychopharmacology and Biological Psychiatry;2024-01

5. Major Neurocognitive Disorders Due to Parkinson’s Disease;Treatment of Psychiatric Disorders Among Older Adults;2024